All News #Library
Biotech
STADA and Bio-Thera Secure EU Approval for Gotenfia
13 Feb 2026 //
PR NEWSWIRE
EMA Recommends Marketing Authorization of AVT03
22 Sep 2025 //
GLOBENEWSWIRE
Bio-Thera, STADA Expand Biosimilars Alliance to Tocilizumab
23 Aug 2025 //
PR NEWSWIRE
NEXGEL and STADA AG Expand North America Partnership
14 Jul 2025 //
GLOBENEWSWIRE
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU
22 Jul 2024 //
GLOBENEWSWIRE
iTeos to raise $120M; Xbrane and STADA to out-license Lucentis biosimilar
10 May 2024 //
ENDPTS
STADA and Alvotech Secure Approval for Uzpruvo
10 Jan 2024 //
GLOBENEWSWIRE
STADA and Alvotech receive positive CHMP opinion for ustekinumab biosimilar
10 Nov 2023 //
GLOBENEWSWIRE
Stada is acquiring additional brands from Sanofi
13 Jul 2023 //
PRESS RELEASE
STADA announces US FDA approves Norbitec biotech facility in Uetersen
27 May 2023 //
PHARMABIZ
EMA Confirms Acceptance of Application for AVT04, Proposed Biosimilar to Stelara
10 Feb 2023 //
STADA
STADA, Xbrane get UK MHRA marketing approval for Ximluci biosimilar Lucentis
19 Jan 2023 //
PHARMABIZ

Market Place
Sourcing Support